Last $59.55 USD
Change Today +2.07 / 3.60%
Volume 2.1M
ISIS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for isis pharmaceuticals inc (ISIS)

Year over year, Isis Pharmaceuticals, Inc. has been able to grow revenues from $102.0M USD to $147.3M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 154.48% to 120.67%. This was a driver that led to an improvement in the bottom line from a loss of $65.5M USD to a smaller loss of $60.6M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Restated
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues108.599.1102.0147.3
TOTAL REVENUES108.599.1102.0147.3
Cost of Goods Sold137.1155.5157.6177.7
GROSS PROFIT-28.6-56.4-55.6-30.4
Selling General & Admin Expenses, Total18.312.812.514.9
OTHER OPERATING EXPENSES, TOTAL18.312.812.514.9
OPERATING INCOME-46.8-69.2-68.1-45.4
Interest Expense-13.2-16.7-21.2-19.4
Interest and Investment Income3.42.41.82.1
NET INTEREST EXPENSE-9.9-14.3-19.3-17.3
Income (Loss) on Equity Investments-6.9-3.6-1.4--
EBT, EXCLUDING UNUSUAL ITEMS-63.6-87.0-88.8-62.6
Gain (Loss) on Sale of Investments3.94.219.82.4
Other Unusual Items, Total-1.5-1.9-5.6-6.3
Other Unusual Items-----4.8--
EBT, INCLUDING UNUSUAL ITEMS-61.2-84.8-74.6-66.6
Income Tax Expense0.10.0-9.1-5.9
Earnings from Continuing Operations-61.3-84.8-65.5-60.6
NET INCOME-61.3-84.8-65.5-60.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-61.3-84.8-65.5-60.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-61.3-84.8-65.5-60.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISIS:US $59.55 USD +2.07

ISIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACADIA Pharmaceuticals Inc $32.85 USD +1.35
Acorda Therapeutics Inc $40.35 USD +1.88
Avanir Pharmaceuticals Inc $16.99 USD +0.07
Depomed Inc $15.72 USD +0.46
Impax Laboratories Inc $30.79 USD +0.86
View Industry Companies
 

Industry Analysis

ISIS

Industry Average

Valuation ISIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 39.5x
Price/Book 19.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 34.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.